The DOI matches its Crossref record; 3 of the 3 references it cites were found in a registry or an index.
Cholesterol 25-Hydroxylase on Chromosome 10q Is a Susceptibility Gene for Sporadic Alzheimer’s Disease
Abstract
Alzheimer’s disease (AD) is the most common cause of dementia. It is characterized by β-amyloid (Aβ) plaques, neurofibrillary tangles and the degeneration of specifically vulnerable brain neurons. We observed high expression of the cholesterol 25-hydroxylase (CH25H) gene in specifically vulnerable brain regions of AD patients. CH25H maps to a region within 10q23 that has been previously linked to sporadic AD. Sequencing of the 5′ region of CH25H revealed three common haplotypes, CH25H χ 2, CH25H χ 3 and CH25H χ 4; CSF levels of the cholesterol precursor lathosterol were higher in carriers of the CH25H χ 4 haplotype. In 1,282 patients with AD and 1,312 healthy control subjects from five independent populations, a common variation in the vicinity of CH25H was significantly associated with the risk for sporadic AD (p = 0.006). Quantitative neuropathology of brains from elderly non-demented subjects showed brain Aβ deposits in carriers of CH25H χ 4 and CH25H χ 3 haplotypes, whereas no Aβ deposits were present in CH25H χ 2 carriers. Together, these results are compatible with a role of CH25H χ 4 as a putative susceptibility factor for sporadic AD; they may explain part of the linkage of chromosome 10 markers with sporadic AD, and they suggest the possibility that CH25H polymorphisms are associated with different rates of brain Aβ deposition.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
An association of CH25H with Alzheimer's disease was first reported in a hippocampal microarray study of AD brain tissue and further suggested by an AlzGene meta-analysis for a sporadic AD population and other AD patient-based independent systematic analyses.
“An association of CH25H with AD was first reported in a hippocampal microarray study of AD brain tissue [53] and further suggested by an AlzGene meta-analysis for a sporadic AD population [54] and other AD patient-based independent systematic analyses [55–57].”
From 25-Hydroxycholesterol amplifies microglial IL-1β production in an apoE isoform-dependent manner (2020) · cites this paper as [54]
CH25H is located on chromosome 10q23, a region strongly linked to AD.
“CH25H is located on chromosome 10q23, a region strongly linked to AD [54].”
From 25-Hydroxycholesterol amplifies microglial IL-1β production in an apoE isoform-dependent manner (2020) · cites this paper as [54]
A significant association of rs13500 'T' allele and haplotypes in the CH25H promoter with the risk of developing AD and with different rates of Aβ/amyloid deposition was previously reported in a large scale AlzGene meta-analysis.
“In a large scale AlzGene meta-analysis including 1282 AD patients and 1312 controls from five independent populations (French, Russian, USA, Swiss, Mediterranean), a significant association of rs13500 ‘T’ allele and haplotypes in the CH25H promoter was previously reported to be associated with the risk of developing AD and with different rates of Aβ/amyloid deposition [54].”
From 25-Hydroxycholesterol amplifies microglial IL-1β production in an apoE isoform-dependent manner (2020) · cites this paper as [54]
Citations
Cites
Neuropathological stageing of Alzheimer-related changes.
Braak, H., & Braak, E. (1991) · Acta Neuropathologica · doi:10.1007/bf00308809 · Cited by 16,123
Self-citationProfound Loss of Layer II Entorhinal Cortex Neurons Occurs in Very Mild Alzheimer’s Disease
Gómez-Isla, T., Price, J. L., McKeel Jr., D. W., Morris, J. C., Growdon, J. H., & Hyman, B. T. (1996) · The Journal of Neuroscience · doi:10.1523/jneurosci.16-14-04491.1996 · Cited by 1,796 · cited 1×
“Alzheimer’s disease (AD) is the most common cause of dementia. It is characterized by β-amyloid (βA) plaques, neurofibrillary tangles (NFTs) and the degeneration of specifically vulnerable brain neurons. Degeneration of neurons in AD occurs predominantly in such brain regions as the hippocampus, the inferior temporal…”
BackgroundIsolation and quantification of soluble Alzheimer's β-peptide from biological fluids
Seubert, P., Vigo-Pelfrey, C., Esch, F., Lee, M., Dovey, H., Davis, D., Sinha, S., Schiossmacher, M., Whaley, J., Swindlehurst, C., et al. (1992) · Nature · doi:10.1038/359325a0 · Cited by 1,731
Flagged first, then by citations
Research works printed but not linked: 27
- 10.1016%2FS0306-4522%2802%2900180-X · DOI
- 10.1074%2Fjbc.273.51.34316 · DOI · Paper page
- 10.1126%2Fscience.290.5500.2302 · DOI
- 10.1093%2Fhmg%2F8.2.237 · DOI
- 10.1002%2Fajmg.10183 · DOI
- 10.1046%2Fj.1471-4159.2001.t01-1-00231.x · DOI
- 10.1007%2Fs00439-004-1107-9 · DOI
- 10.1002%2Fhumu.20012 · DOI
- 10.1016%2Fj.nbd.2004.09.011 · DOI
- 10.1001%2Farchneur.60.1.29 · DOI
- 10.1016%2FS0197-4580%2802%2900094-5 · DOI
- 10.1038%2Fsj.mp.4001296 · DOI
- 10.1192%2Fbjp.140.6.566 · DOI · Paper page
- 10.1006%2Fabio.1995.1110 · DOI
- 10.1054%2Fmodi.2000.19218 · DOI
- 10.1038%2Fsj.ejhg.5200625 · DOI
- 10.1074%2Fjbc.273.23.14538 · DOI
- 10.1093%2Fnar%2F27.10.2211 · DOI
- 10.1210%2Fme.15.5.812 · DOI
- 10.1093%2Fnar%2F23.23.4878 · DOI
- 10.1016%2F0039-128X%2894%2900002-T · DOI
- 10.1210%2Fen.140.7.3034 · DOI
- 10.1016%2Fj.expneurol.2003.09.004 · DOI
- 10.1126%2Fscience.290.5500.2303 · DOI
- 10.1126%2Fscience.290.5500.2304 · DOI
- 10.1002%2Fana.410380413 · DOI · Paper page
- 10.1016%2FS0196-9781%2802%2900056-6 · DOI
Cited by
Sorted by citations
Necroptosis and RIPK1-mediated neuroinflammation in CNS diseases
Yuan, J., Amin, P., & Ofengeim, D. (2019) · Nature Reviews Neuroscience · doi:10.1038/s41583-018-0093-1 · Cited by 967
Thirty years of Alzheimer's disease genetics: the implications of systematic meta-analyses
Bertram, L., & Tanzi, R. E. (2008) · Nature Reviews Neuroscience · doi:10.1038/nrn2494 · Cited by 747
The Possibility of an Infectious Etiology of Alzheimer Disease
Ashraf, G. M., Tarasov, V. V., Makhmutovа, A., Chubarev, V. N., Avila-Rodriguez, M., Bachurin, S. O., & Aliev, G. (2019) · Molecular Neurobiology · doi:10.1007/s12035-018-1388-y · Cited by 175
Examination of the current top candidate genes for AD in a genome-wide association study
Feulner, T. M., Laws, S. M., Friedrich, P., Wagenpfeil, S., Wurst, S. H. R., Riehle, C., Kuhn, K. A., Krawczak, M., Schreiber, S., Nikolaus, S., et al. (2010) · Molecular Psychiatry · doi:10.1038/mp.2008.141 · Cited by 128
Infectious agents and Alzheimer's disease
Piekut, T., Hurła, M., Banaszek, N., Szejn, P., Dorszewska, J., Kozubski, W., & Prendecki, M. (2022) · Journal of Integrative Neuroscience · doi:10.31083/j.jin2102073 · Cited by 123
25-Hydroxycholesterol amplifies microglial IL-1β production in an apoE isoform-dependent manner
Wong, M. Y., Lewis, M., Doherty, J. J., Shi, Y., Cashikar, A. G., Amelianchik, A., Tymchuk, S., Sullivan, P. M., Qian, M., Covey, D. F., et al. (2020) · Journal of Neuroinflammation · doi:10.1186/s12974-020-01869-3 · Cited by 121
Thal, D. R., Papassotiropoulos, A., Saido, T. C., Griffin, W. S. T., Mrak, R. E., Kölsch, H., Tredici, K. D., Attems, J., & Ghebremedhin, E. (2010) · Acta Neuropathologica · doi:10.1007/s00401-010-0707-9 · Cited by 103
Self-citation
Metadata
- Authors
- Papassotiropoulos, A., Lambert, J.-C., Wavrant-De Vrièze, F., Wollmer, M. A., von der Kammer, H., Streffer, J. R., Maddalena, A., Huynh, K.-D., Wolleb, S., Lütjohann, D., Schneider, B., Thal, D. R., Grimaldi, L. M. E., Tsolaki, M., Kapaki, E., Ravid, R., Konietzko, U., Hegi, T., Pasch, T., Jung, H., Braak, H., Amouyel, P., Rogaev, E. I., Hardy, J., Hock, C., & Nitsch, R. M.
- Venue
- Neurodegenerative Diseases
- Publisher
- S. Karger AG
- Published
- 2005
- Volume
- 2
- Issue
- 5
- Pages
- 233-241
- ISSN
- 1660-2854
- 1660-2862
- Cited by
- 51
- References
- 3
- Language
- en
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review